Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone and Cinacalcet in Primary Hyperparathyroidism
NCT02525796Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2016
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of eplerenone in primary hyperparathyroidism (PHPT), sponsored by Brigham and Women's Hospital. Started Jan 2016; status: completed.
02
Drugs
eplerenone
03
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on NCT02525796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02525796.